One of the novel biomarkers possibly involved in the carcinogenesis of many tumors, including HNSCC, is the insulin-like growth factor II m-RNA-binding protein 3 (IMP3) [12]. The gene discussed is IMP3; the disease is head and neck squamous cell carcinoma.